ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Bayer Gets Korean Imaging Technology

February 25, 2008 | APPEARED IN VOLUME 86, ISSUE 8

Bayer Schering Pharma has licensed worldwide rights to a novel fluorine-18 radiolabeling technology from FutureChem, part of South Korea's Asan Medical Center. Bayer says the technology can be used to label target-specific tracers for positron emission tomography and other molecular imaging techniques. FutureChem's labeling process includes a nucleophilic substitution reaction that, according to Bayer, results in yields 5 to 50 times larger than those achieved with existing technologies.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment